Dominari Holdings (DE:BP2A)
FRANKFURT:BP2A
Holding DE:BP2A?
Track your performance easily

Dominari Holdings (BP2A) Stock Price & Analysis

0 Followers

BP2A Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

35.07%4.19%<0.01%57.22%
35.07% Insiders
<0.01% Other Institutional Investors
57.22% Public Companies and
Individual Investors

BP2A FAQ

What was Dominari Holdings’s price range in the past 12 months?
Dominari Holdings lowest stock price was €1.35 and its highest was €2.84 in the past 12 months.
    What is Dominari Holdings’s market cap?
    Currently, no data Available
    When is Dominari Holdings’s upcoming earnings report date?
    Dominari Holdings’s upcoming earnings report date is Nov 11, 2021 which is 1099 days ago.
      How were Dominari Holdings’s earnings last quarter?
      Dominari Holdings released its earnings results on Mar 12, 2019. The company reported €43.7 earnings per share for the quarter, beating the consensus estimate of N/A by €43.7.
        Is Dominari Holdings overvalued?
        According to Wall Street analysts Dominari Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Dominari Holdings pay dividends?
          Dominari Holdings pays a Annually dividend of €0.11 which represents an annual dividend yield of N/A. See more information on Dominari Holdings dividends here
            What is Dominari Holdings’s EPS estimate?
            Dominari Holdings’s EPS estimate is €0.
              How many shares outstanding does Dominari Holdings have?
              Dominari Holdings has 6,276,138 shares outstanding.
                What happened to Dominari Holdings’s price movement after its last earnings report?
                Dominari Holdings reported an EPS of €43.7 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
                  Which hedge fund is a major shareholder of Dominari Holdings?
                  Currently, no hedge funds are holding shares in DE:BP2A
                  ---

                  Dominari Holdings Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -19.90%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -46.97%
                  Trailing 12-Months
                  Asset Growth
                  -31.29%
                  Trailing 12-Months

                  Company Description

                  Dominari Holdings

                  Spherix, Inc. is a biotechnology development company, which engages in the provision of diversified commercialization platform for protected technologies. The firm's activities include the acquisition and development of patents through internal or external research and development. Its patent portfolio consists of patents in the fields of wireless communications, satellite, solar and radio frequency, as well as 2 U.S. patents in pharmaceutical technology. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Aethlon Medical
                  Medicinova
                  Can-Fite BioPharma
                  Evofem Biosciences
                  Dominari Holdings
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis